Women and Atrial Fibrillation: Is the Disparity in Anticoagulation Just a Question of Gender? In Search of the Brazilian Reality.
作者信息
Elias Neto Jorge, Gomes Fernando Luiz Torres
机构信息
Vitoria Apart Hospital - Serviço de Eletrofisiologia, Serra, ES - Brasil.
Hospital Universitário Cassiano Antônio Moraes, Vitoria, ES - Brasil.
出版信息
Arq Bras Cardiol. 2024 Nov 22;121(9):e20240583. doi: 10.36660/abc.20240583. eCollection 2024.
Abstract
摘要
相似文献
1
Women and Atrial Fibrillation: Is the Disparity in Anticoagulation Just a Question of Gender? In Search of the Brazilian Reality.女性与心房颤动：抗凝治疗的差异仅仅是性别问题吗？探寻巴西的实际情况。
Arq Bras Cardiol. 2024 Nov 22;121(9):e20240583. doi: 10.36660/abc.20240583. eCollection 2024.
2
Gender Differences in Antithrombotic Treatment for Newly Diagnosed Atrial Fibrillation: The GLORIA-AF Registry Program.新发心房颤动抗栓治疗的性别差异：GLORIA-AF 登记研究。
Am J Med. 2018 Aug;131(8):945-955.e3. doi: 10.1016/j.amjmed.2018.03.024. Epub 2018 Apr 11.
3
Racial and Sex Disparities in Anticoagulation After Electrical Cardioversion for Atrial Fibrillation and Flutter.种族和性别差异在电复律治疗心房颤动和扑动后的抗凝治疗中。
J Am Heart Assoc. 2021 Sep 7;10(17):e021674. doi: 10.1161/JAHA.121.021674. Epub 2021 Aug 25.
4
Efficacy and Safety of Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation Undergoing Elective Surgical Procedures: A Meta-analysis.围手术期桥接抗凝在择期手术的房颤患者中的疗效和安全性：一项荟萃分析。
Clin Med Res. 2021 Mar;19(1):19-25. doi: 10.3121/cmr.2020.1546. Epub 2020 Oct 14.
5
The Canadian Community Utilization of Stroke Prevention Study in Atrial Fibrillation in the Emergency Department (C-CUSP ED).加拿大社区在急诊科应用卒中预防治疗心房颤动研究（C-CUSP ED）。
Ann Emerg Med. 2019 Apr;73(4):382-392. doi: 10.1016/j.annemergmed.2018.09.001. Epub 2018 Oct 26.
6
Percutaneous left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation and contraindication for anticoagulation.经皮左心耳封堵术用于房颤且有抗凝禁忌证患者的卒中预防
Rev Neurol (Paris). 2015 May;171(5):426-32. doi: 10.1016/j.neurol.2014.11.009. Epub 2015 Apr 23.
7
'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.“真实世界”的心房颤动抗栓治疗：EORP-AF 初步调查。
Am J Med. 2014 Jun;127(6):519-29.e1. doi: 10.1016/j.amjmed.2013.12.022. Epub 2014 Jan 28.
8
Atrial fibrillation or flutter and stroke: a Danish population-based study of the effectiveness of oral anticoagulation in clinical practice.心房颤动或心房扑动与中风：一项基于丹麦人群的关于临床实践中口服抗凝治疗效果的研究。
J Intern Med. 2002 Jul;252(1):64-9. doi: 10.1046/j.1365-2796.2002.01009.x.
9
Introduction of Non-Vitamin K Antagonist Anticoagulants Strongly Increased the Rate of Anticoagulation in Hospitalized Geriatric Patients with Atrial Fibrillation.非维生素K拮抗剂类抗凝剂的引入显著提高了老年房颤住院患者的抗凝率。
Drugs Aging. 2018 Sep;35(9):859-869. doi: 10.1007/s40266-018-0571-1.
10
What is the optimal anticoagulation management of patients post-cardiac surgery who go into atrial fibrillation?心脏手术后发生房颤的患者的最佳抗凝管理是什么？
Interact Cardiovasc Thorac Surg. 2004 Sep;3(3):503-9. doi: 10.1016/j.icvts.2004.05.004.
本文引用的文献
1
Lack of Anticoagulant Use in Patients with Atrial Fibrillation and Increased Risk of Thromboembolic Events According to Sex: Insights from a Multicentric Brazilian Study.根据性别分析伴有血栓栓塞事件风险增加的房颤患者抗凝治疗不足：一项多中心巴西研究的结果。
Arq Bras Cardiol. 2024 Sep;121(9):e20240310. doi: 10.36660/abc.20240310.
2
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2023 ACC/AHA/ACCP/HRS 指南：心房颤动的诊断与管理——美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
Circulation. 2024 Jan 2;149(1):e1-e156. doi: 10.1161/CIR.0000000000001193. Epub 2023 Nov 30.
3
Sex-related differences in presentation, treatment, and outcomes of Asian patients with atrial fibrillation: a report from the prospective APHRS-AF Registry.亚洲心房颤动患者的临床表现、治疗和结局的性别差异：前瞻性亚太心律学会心房颤动登记研究报告。
Sci Rep. 2023 Oct 26;13(1):18375. doi: 10.1038/s41598-023-45345-3.
4
Race, ethnicity, sex, and socioeconomic disparities in anticoagulation for atrial fibrillation: A narrative review of contemporary literature.种族、民族、性别和社会经济差异在心房颤动抗凝治疗中的作用：当代文献的叙述性综述。
J Natl Med Assoc. 2023 Jun;115(3):290-297. doi: 10.1016/j.jnma.2023.02.008. Epub 2023 Mar 5.
5
Sex Differences in the Management of Oral Anticoagulation and Outcomes for Emergency Department Presentation of Incident Atrial Fibrillation.急诊就诊的新发心房颤动患者抗凝治疗管理及结局的性别差异。
Ann Emerg Med. 2022 Aug;80(2):97-107. doi: 10.1016/j.annemergmed.2022.03.010. Epub 2022 Apr 22.
6
Sex Differences in Atrial Fibrillation.心房颤动中的性别差异
Circ J. 2022 Jul 25;86(8):1217-1218. doi: 10.1253/circj.CJ-21-1072. Epub 2022 Feb 1.
7
Sex differences in treatment strategy and adverse outcomes among patients 75 and older with atrial fibrillation in the MarketScan database.市场扫描数据库中 75 岁及以上房颤患者的治疗策略和不良结局的性别差异。
BMC Cardiovasc Disord. 2021 Dec 16;21(1):598. doi: 10.1186/s12872-021-02419-2.
8
Female Sex as a Thromboembolic Risk Factor in the Era of Nonvitamin K Antagonist Oral Anticoagulants.女性性别是非维生素 K 拮抗剂口服抗凝剂时代的血栓栓塞风险因素。
Cardiovasc Ther. 2020 Jun 18;2020:1743927. doi: 10.1155/2020/1743927. eCollection 2020.
9
Sex Differences in Oral Anticoagulation and Outcomes of Stroke and Intracranial Bleeding in Newly Diagnosed Atrial Fibrillation.新发心房颤动患者中口服抗凝药物的使用与卒中和颅内出血结局的性别差异。
J Am Heart Assoc. 2020 May 18;9(10):e015689. doi: 10.1161/JAHA.120.015689. Epub 2020 May 12.
10
DOACS in women: pros and cons.口服抗凝药物在女性中的应用：利弊分析。
Thromb Res. 2019 Sep;181 Suppl 1:S19-S22. doi: 10.1016/S0049-3848(19)30361-5.
Zotero 插件